Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathon D S Holt

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Advanced Drug Delivery Reviews|February 24, 2015
Acceptability and preferences for vaginal dosage forms intended for prevention of HIV or HIV and pregnancyCynthia Woodsong, Jonathon D S Holt
Current Topics in Microbiology and Immunology|April 25, 2013
Preclinical safety evaluationJonathon D S Holt, Jeremy P Nuttall
Antimicrobial Agents and Chemotherapy|April 8, 2015
The sheep as a model of preclinical safety and pharmacokinetic evaluations of candidate microbicidesJonathon D S Holt, David Cameron, Nicola Dias, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 17, 2016
Controlling levonorgestrel binding and release in a multi-purpose prevention technology vaginal ring deviceDiarmaid J Murphy, Peter Boyd, Clare F McCoy, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 29, 2005
ARD-353 [4-((2R,5S)-4-(R)-(4-diethylcarbamoylphenyl)(3-hydroxyphenyl)methyl)-2,5-dimethylpiperazin-1-ylmethyl)benzoic acid], a novel nonpeptide delta receptor agonist, reduces myocardial infarct size without central effectsMichael J Watson, Jonathon D S Holt, Scott J O'Neill, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 16, 2005
DPI-221 [4-((alpha-s)-alpha-((2s,5r)-2,5-dimethyl-4-(3-fluorobenzyl)-1-piperazinyl)benzyl)-N,N-diethylbenzamide]: a novel nonpeptide delta receptor agonist producing increased micturition interval in normal ratsJonathon D S Holt, Michael J Watson, Jane P Chang, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 9, 2018
Pharmacokinetic/Pharmacodynamic Correlation Analysis of Amantadine for Levodopa-Induced DyskinesiaElizabeth F Brigham, Tom H Johnston, Carl Brown, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Advanced Drug Delivery Reviews|February 24, 2015
Acceptability and preferences for vaginal dosage forms intended for prevention of HIV or HIV and pregnancyCynthia Woodsong, Jonathon D S Holt
Current Topics in Microbiology and Immunology|April 25, 2013
Preclinical safety evaluationJonathon D S Holt, Jeremy P Nuttall
Antimicrobial Agents and Chemotherapy|April 8, 2015
The sheep as a model of preclinical safety and pharmacokinetic evaluations of candidate microbicidesJonathon D S Holt, David Cameron, Nicola Dias, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 17, 2016
Controlling levonorgestrel binding and release in a multi-purpose prevention technology vaginal ring deviceDiarmaid J Murphy, Peter Boyd, Clare F McCoy, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 29, 2005
ARD-353 [4-((2R,5S)-4-(R)-(4-diethylcarbamoylphenyl)(3-hydroxyphenyl)methyl)-2,5-dimethylpiperazin-1-ylmethyl)benzoic acid], a novel nonpeptide delta receptor agonist, reduces myocardial infarct size without central effectsMichael J Watson, Jonathon D S Holt, Scott J O'Neill, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 16, 2005
DPI-221 [4-((alpha-s)-alpha-((2s,5r)-2,5-dimethyl-4-(3-fluorobenzyl)-1-piperazinyl)benzyl)-N,N-diethylbenzamide]: a novel nonpeptide delta receptor agonist producing increased micturition interval in normal ratsJonathon D S Holt, Michael J Watson, Jane P Chang, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 9, 2018
Pharmacokinetic/Pharmacodynamic Correlation Analysis of Amantadine for Levodopa-Induced DyskinesiaElizabeth F Brigham, Tom H Johnston, Carl Brown, et al.
Pageof 1